Providing a diverse range of perspectives from bullish to bearish, 13 analysts have published ratings on Chewy CHWY in the last three months.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 8 | 1 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 2 | 6 | 1 | 0 | 0 |
| 2M Ago | 1 | 0 | 0 | 0 | 0 |
| 3M Ago | 1 | 1 | 0 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $38.0, along with a high estimate of $42.00 and a low estimate of $28.00. This upward trend is evident, with the current average reflecting a 15.15% increase from the previous average price target of $33.00.
Deciphering Analyst Ratings: An In-Depth Analysis
The standing of Chewy among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Nicholas Jones | JMP Securities | Maintains | Market Outperform | $37.00 | $37.00 |
| Doug Anmuth | JP Morgan | Raises | Overweight | $38.00 | $37.00 |
| Alexandra Steiger | Goldman Sachs | Raises | Buy | $40.00 | $35.00 |
| Steven Shemesh | RBC Capital | Raises | Outperform | $42.00 | $39.00 |
| Peter Keith | Piper Sandler | Raises | Overweight | $40.00 | $35.00 |
| Lauren Schenk | Morgan Stanley | Raises | Overweight | $36.00 | $33.00 |
| Justin Kleber | Baird | Raises | Outperform | $40.00 | $35.00 |
| Lee Horowitz | Deutsche Bank | Raises | Hold | $28.00 | $24.00 |
| Curtis Nagle | B of A Securities | Raises | Buy | $40.00 | $24.00 |
| Trevor Young | Barclays | Raises | Overweight | $40.00 | $34.00 |
| Steven Zaccone | Citigroup | Raises | Buy | $40.00 | $28.00 |
| Bill Kerr | TD Cowen | Announces | Buy | $38.00 | - |
| Peter Keith | Piper Sandler | Maintains | Overweight | $35.00 | $35.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Chewy. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Chewy compared to the broader market.
- Price Targets: Gaining insights, analysts provide estimates for the future value of Chewy's stock. This comparison reveals trends in analysts' expectations over time.
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Chewy's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
Stay up to date on Chewy analyst ratings.
All You Need to Know About Chewy
Chewy is the largest e-commerce petcare retailer in the US, generating $11.2 billion in 2023 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods, like crates, leashes, and bowls.
Chewy's Financial Performance
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Positive Revenue Trend: Examining Chewy's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 4.8% as of 31 October, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: Chewy's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 0.14%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Chewy's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 1.11%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Chewy's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.13%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: With a high debt-to-equity ratio of 2.29, Chewy faces challenges in effectively managing its debt levels, indicating potential financial strain.
Analyst Ratings: Simplified
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
